Medication reference
Fentanyl
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Fentanyl (opens in a new tab)Original source URL: https://globalrph.com/dilution/fentanyl/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/fentanyl/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:46:47.266245+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- a2022b1a2af084d95bd3744e045aee85f5999d5b3e7e758e0a40bc651e595caf
- Original response SHA-256
- f074a3ecc96332911677b6b92cb3b3abf422b0e017e3a45ad96058cd766dbd22
- Source body SHA-256
- 5df4a1eed79781e63eb5f6e6101cb70a0fc6855a449bbc0ac1e4a90444527eba
FENTANYL |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Usual Diluents |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NS, D5W | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| [0 - 5000 mcg] [50-250ml] [Titrate] [1250 mcg] [250 ml] [Titrate] [2500 mcg] [250 ml] [Titrate] [5000 mcg] [250 ml] [Titrate] (May concentrate further) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stability / Miscellaneous |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Minimum dilution: 2500 to 5000 mcg/ 50 ml. Adults: Adjunct to regional anesthesia: I.M., slow I.V.: 50-100 mcg/dose; if I.V. used, give over 1-2 minutes Severe pain: I.M.: 50-100 mcg/dose every 1-2 hours as needed; patients with prior opiate exposure may tolerate higher initial doses Adjunct to general anesthesia: Slow I.V.: High dose: Initial: 20-50 mcg/kg/dose; Maintenance: 25 mcg to one-half the initial loading dose may be given as needed General anesthesia without additional anesthetic agents: Slow I.V.: 50-100 mcg/kg with O2 and skeletal muscle relaxant Mechanically-ventilated patients (based on 70 kg patient): Slow I.V.: 0.35-1.5 mcg/kg every 30-60 minutes as needed; infusion: 0.7 - 10 mcg/kg/hour Patient-controlled analgesia (PCA): I.V.: Usual concentration: 50 mcg/mL -------------------------------------------------------------------------------- DOSAGE AND ADMINISTRATION Dosage should be individualized. Some of the factors to be considered in determining the dose are age, body weight, physical status, underlying pathological condition, use of other drugs, type of anesthesia to be used and the surgical procedure involved. Dosage should be reduced in elderly or debilitated patients. Vital signs should be monitored routinely. I.Premedication- Premedication (to be appropriately modified in the elderly, debilitated, and those who have received other depressant drugs)-50 mcg to 100 mcg (0.05 mg to 0.1 mg) (1 mL to 2 mL) may be administered intramuscularly 30 to 60 minutes prior to surgery. II.Adjunct to General Anesthesia- See Dosage Range Chart III.Adjunct to Regional Anesthesia- 50 mcg to 100 mcg (0.05 mg to 0.1 mg) (1 mL to 2 mL) may be administered intramuscularly or slowly intravenously, over one to two minutes, when additional analgesia is required. IV.Postoperatively (recovery room)- 50 mcg to 100 mcg (0.05 mg to 0.1 mg) (1 mL to 2 mL) may be administered intramuscularly for the control of pain, tachypnea, and emergence delirium. The dose may be repeated in one to two hours as needed. Usage in Children: For induction and maintenance in children 2 to 12 years of age, a reduced dose as low as 2 mcg/kg to 3 mcg/kg is recommended. DOSAGE RANGE CHART
As a General Anesthetic: As noted above, it is essential that qualified personnel and adequate facilities be available for the management of respiratory depression. See package insert for WARNINGS and PRECAUTIONS for use of fentanyl with other CNS depressants, and in patients with altered response. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. HOW SUPPLIED
PROTECT FROM LIGHT. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Revised: April, 2007 Source: [package insert] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Pain Management / Palliative Care resources
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- current_label_review_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- fentanyl
Source ID
H51-08BE96338526854050BF8B28 - Generic name
- Fentanyl
Source ID
H51-F0D97DD6C1BA088AAF200374 - Class
- Sedation, analgesia, and anesthesia
Source ID
H51-EF8EAF853F9DBA93E8955EA3 - Subclass
- Opioid analgesic
Source ID
H51-3704C0A9C88CAFEFF4EBD05A - Primary uses
- Severe pain
Source ID
H51-32F3E74C18374975E003C7C7 - Procedural analgesia
Source ID
H51-3713D5147108F1637C6741BC - ICU analgesia and sedation
Source ID
H51-D35A001A04C277A76CDC21E0
- Severe pain
- Mechanism
- Agonizes mu-opioid receptors and suppresses nociceptive neurotransmission while depressing respiratory drive.
Source ID
H51-01748F14C6EEB16B2AB6CDA7 - Mechanism level
- drug_specific
Source ID
H51-4C35E0C67215D146E03F2055 - Basic dosing orientation
- Adult infusion | Existing preparation record; use current package insert for indication-specific selection | Patient-specific dose; common bag 1,000 or 2,500 mcg | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Common incremental dose 25 to 100 mcg | Common incremental dose 25 to 100 mcg | Patient- and indication-specific | See current package insert | IV push
Source ID
H51-D225413523FFEE8A32D8568A - Administration orientation
- Titrate by mcg/hour or mcg/kg/hour; Slow IV over 1 to 2 minutes; 50 mcg/mL may be given undiluted or diluted per policy; Slow IV over 1 to 2 minutes
Source ID
H51-09505A77E6C475E842B212B8 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-1C4D9EB593547BBC6C66D34E - Key safety orientation
- Respiratory depression, apnea, hypotension, and chest wall rigidity.
Source ID
H51-C005AA050CEBFD3B09140644 - Concomitant sedatives increase risk.
Source ID
H51-651E8490D8C82DF6FA5843EC
- Respiratory depression, apnea, hypotension, and chest wall rigidity.
- Coverage path
- structured_local_snapshot
Source ID
H51-3D12E8C6DA0DDA231A53078A - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-E1DE7F2458716A3FCF031B4E - Legacy title
- Fentanyl
Source ID
H51-E755B655070DA6F9E7DA362B - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-56E4BD09F57405A73542BBD0 - Search text
- Fentanyl Sedation, analgesia, and anesthesia Opioid analgesic Severe pain Procedural analgesia ICU analgesia and sedation Agonizes mu-opioid receptors and suppresses nociceptive neurotransmission while depressing respiratory drive. Adult infusion | Existing preparation record; use current package insert for indication-specific selection | Patient-specific dose; common bag 1,000 or 2,500 mcg | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Common incremental dose 25 to 100 mcg | Common incremental dose 25 to 100 mcg | Patient- and indication-specific | See current package insert | IV push Titrate by mcg/hour or mcg/kg/hour; Slow IV over 1 to 2 minutes; 50 mcg/mL may be given undiluted or diluted per policy; Slow IV over 1 to 2 minutes Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Respiratory depression, apnea, hypotension, and chest wall rigidity. Concomitant sedatives increase risk. Structured GlobalRPh route snapshot
Source ID
H51-D4A9E8DC82C221F93F7ED886 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Fentanyl (opens in a new tab)
Source ID
H51-5C058A7C9076A7F68557927F - Official access mode
- search
Source ID
H51-5908DB30FD14906FC40B4E3C - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Fentanyl (opens in a new tab)
Source ID
H51-B312BCB7B04922937D35F373 - Official search query
- Fentanyl
Source ID
H51-E6C049FF9C2FEA92A686DBF0 - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-97F369DF652C52ACF4C266EC
No separate structured rows were bundled for dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-233D27322DDA921EA9959B65Source IDH51-D70AB7A1EF1453789F5A1728 | Patient-specific dose; common bag 1,000 or 2,500 mcgSource IDH51-AD585CCF1B6E88BEF8E063E0 | Dilute concentrate or use premix.Source IDH51-5DDB8A51464E6B4422724492 | NS or D5WSource IDH51-5AE2329D48DE0049E031C323 | 100 to 250 mLSource IDH51-9B4FE63CC88372B0104DD903 | Commonly 10 to 50 mcg/mLSource IDH51-D2D84BA1DBA4D760B80DDC52 | Titrate by mcg/hour or mcg/kg/hourSource IDH51-B4E101806A0FE539E8EC8764 | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-7002235CB1C9C129F6A1B5B5 | Standardize concentration and dosing units.Source IDH51-84354955E54D574FDB0BB4F2 |
Historical IV-push guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Dose scope | Concentration | Rate | Status | Notes |
|---|---|---|---|---|---|
Source IDH51-A758FCB485AFB02A7F12FE96Source IDH51-D25E34B88C48BA1FFCBA21B7 | Common incremental dose 25 to 100 mcgSource IDH51-B15366C74C7F28686DCC5B5F | 50 mcg/mL may be given undiluted or diluted per policySource IDH51-ACAA1C9CC362266391C0C7B9 | Slow IV over 1 to 2 minutesSource IDH51-D72DCBDBE517121A7D534ABD | Allowed with opioid monitoringSource IDH51-7EF7E757737288DBE1182FC5 | Rapid administration can cause chest wall rigidity, especially with large doses.Source IDH51-401DD59FFB41591AB1173F42 |
Source IDH51-B511E03D0640968917F5FEE0Source IDH51-927253A5E66498C4D8A86727 | Weight-based doseSource IDH51-E4EB1F737D26827561C32053 | Diluted or undiluted per age and policySource IDH51-F21471F106E73384C29E3384 | Slow IV over 1 to 3 minutesSource IDH51-61E90E8DBF613A8B14E4A3E4 | Pediatric protocol requiredSource IDH51-FB8C54B93C2DC970CCF6EF5F |
Historical continuous-infusion guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Standard concentration | Initial rate | Titration | Maximum | Notes |
|---|---|---|---|---|---|
Source IDH51-66A0237AF792EACC79E6F296Source IDH51-540F014C9223E28CD3CCF356 | 10 to 50 mcg/mL standardized concentrationSource IDH51-7D2CD836B50ED9B2DEA5B503 | 25 to 50 mcg/hour commonlySource IDH51-366C31ED6EFC7FB30414FA10 | Titrate to pain/sedation goalSource IDH51-42F844AB75B925DD1DAB3717 | Protocol-specificSource IDH51-BEFFB9356014B0148A4FDF0A | Account for accumulation and interactions.Source IDH51-968B5023C6370EC13CC22EF4 |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-B4740A7EAA9B0025CC1FD78ASource IDH51-E79A2100AC80E1F25C097CB9 | Adult infusionSource IDH51-19B15B1C745D2DA795CB4084 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-D66258A1692876C876ABDD88 | Patient-specific dose; common bag 1,000 or 2,500 mcgSource IDH51-88F5846920CECF49B3085798 | Not normalized in the preparation recordSource IDH51-8141CDA700702E56CE538A42 | See current package insert and professional guidanceSource IDH51-9A328E57E386FED52A43DE98 | Titrate by mcg/hour or mcg/kg/hourSource IDH51-E01A8436E6FCE8D9F5225A53 | Existing GlobalRPh structured preparation snapshotSource IDH51-0E60F9442D36E4F126F5A3A4 | Standardize concentration and dosing units.Source IDH51-C8948BDC424A32E5022EEA04 |
Source IDH51-CAE63CE7245CA03A50CB4BE9Source IDH51-0707188DE73EF3ACA5FA3847 | AdultSource IDH51-5C72C750B39F69FDE19BDEC3 | Common incremental dose 25 to 100 mcgSource IDH51-B77F1432641DA65F1D9DDA6C | Common incremental dose 25 to 100 mcgSource IDH51-5EBB1A2F0D338E6F2B00991E | Patient- and indication-specificSource IDH51-E389BD895AAD7DB5B74706A8 | See current package insertSource IDH51-ED28F3F94963AF47B51EB723 | Slow IV over 1 to 2 minutesSource IDH51-5AD3247A5E974A1009BA1963 | Existing GlobalRPh IV push snapshotSource IDH51-9570EB03EC74A8B3F6C88130 | Allowed with opioid monitoring Rapid administration can cause chest wall rigidity, especially with large doses.Source IDH51-DEB721B93B570052B1102390 |
Source IDH51-7B948372CBE0BA06CF5131A4Source IDH51-4952FD40A25F63B11D8EAC8D | PediatricSource IDH51-C63A216AB3C2B6C54F35EC34 | Weight-based doseSource IDH51-16F7D0821BDAA17DC258D068 | Weight-based doseSource IDH51-CA2294C7229AB7A93DA4032E | Patient- and indication-specificSource IDH51-99D6BB8D507F1D5E0F1FBA8B | See current package insertSource IDH51-A19E96058EFEB902F6D0F647 | Slow IV over 1 to 3 minutesSource IDH51-A33D1CE939320AE08B32DCCA | Existing GlobalRPh IV push snapshotSource IDH51-B14F2096635D5BA7E5B5F7D6 | Pediatric protocol requiredSource IDH51-368AC37AF1083046B4051579 |
Source IDH51-07FA86B2D47A26B6B19177FASource IDH51-9E184A47918C2FE94E8141D4 | AdultSource IDH51-4D0544870A83BEA9943F0232 | Existing continuous-infusion recordSource IDH51-3A7D5ACC7F8D1D887EF65D67 | 25 to 50 mcg/hour commonlySource IDH51-42A1902868A9633AAE6A3A0F | Continuous infusion; titration-specificSource IDH51-1692988151B7041175FB2033 | Clinical-response dependentSource IDH51-9424B098FF04618D8FADC488 | Titrate to pain/sedation goalSource IDH51-9B4D611AB7319502D79E860B | Existing GlobalRPh continuous-infusion snapshotSource IDH51-5F96767C09C7DFB69CDC24D3 | Protocol-specific Account for accumulation and interactions.Source IDH51-F7C8354CF22E2976ACEDE72A |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- current_label_review_required
Source ID
H51-41E73D0EF4C6216C8DD0A53E - Summary
- Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-E537777DC8261F395BAE6B39 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-AE14236F46024A5330698DC0
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Severe pain
Source ID
H51-085CB1778D5DAB3B4F45C0E2 - Procedural analgesia
Source ID
H51-8A1E45B5A031A916B88D2B6A - ICU analgesia and sedation
Source ID
H51-3EB280BA6EE60EC399151004
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Respiratory depression, apnea, hypotension, and chest wall rigidity.
Source ID
H51-DD3B93F3209ABF8E32DD967B - Concomitant sedatives increase risk.
Source ID
H51-1AABA60771B823C3A6487055
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
- Continuous oxygenation and ventilation as clinically indicated
Source ID
H51-6461158547682E620F1561A2 - Sedation and pain scores
Source ID
H51-273715E42BE6627FB48277D8 - Blood pressure
Source ID
H51-8A59133C75CE204F21464C15
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
fentanylSource ID
H51-94607B6BC2D935A50E4245ADGeneric name
FentanylSource ID
H51-2C2FC1D2FDBC3BE5FA14645FBrand names
- Sublimaze
Source ID
H51-586364D5B0CF4CF9C38E2577
Class
Sedation, analgesia, and anesthesiaSource ID
H51-C7B473FC50A8BA1FAD57B233Subclass
Opioid analgesicSource ID
H51-920F841AB0423AF90DB45568Summary
Potent opioid used by slow IV injection or continuous infusion with respiratory and sedation monitoring.Source ID
H51-4548E17485313E46148A6E8CPopulations
- Adult
Source ID
H51-EFB295CA84E31853AF53FFB2 - Pediatric
Source ID
H51-2AEF461371DD94F2E875012A - Neonatal
Source ID
H51-60F4CEE0A1BE997651A3FAE2
Evidence tier
Core reference - verify current labelSource ID
H51-56D9673972927C08053848B9High alert
trueSource ID
H51-B7ECD1B8F92FE9FB57DC4363Hazardous
falseSource ID
H51-FA99D64D442728D2F11DB431Status
ActiveSource ID
H51-05220F136CBA81F49ACAECA4Reviewed
2026-08-29Source ID
H51-020B19918ED8CBADE72A84FDVersion added
1.0Source ID
H51-8C47D19E71C0E7CCAC5ED3DDSources
| Label | Url | Kind |
|---|---|---|
Source IDH51-36FBC1846FA13F98A897433BSource IDH51-F7BD2D5F8903C84647EC1B14 | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fentanyl (opens in a new tab)Source IDH51-B0932E7598BCAAE5FB46D436 | PrimarySource IDH51-722959DC22BC38938F56EE14 |
Source IDH51-C83047E1392E58A3B4F7F115Source IDH51-D3886AF1113EBD99B4F2DE18 | legacy:autoSource IDH51-11E39F1A01880F0FFB3E34D4 | LegacySource IDH51-459DB341443BCD46F225DA25 |
Legacy title
FentanylSource ID
H51-612F3D45A066894E911C36B5Clinical release verification
- Audit version
- 3.4
Source ID
H51-EB1356531669901C43811FE3 - Audited on
- 2026-08-30
Source ID
H51-5024EAD5CE9DC9440697F31D - Level
- amber
Source ID
H51-63D472ED8BA69B13218684AA - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-40ECE910F07600000BDA3359 - Exact current label candidate
- false
Source ID
H51-48287B25B5640DA7AE1A280A - Numeric support ratio
- 0
Source ID
H51-DC9129E1D1630334CC9F84F1 - Reference url count
- 1
Source ID
H51-4CF3B8E3D3EE4E17A6A29170 - Broken reference count
- 0
Source ID
H51-BE2980F6B96961D34BCAD53B - Point of use confirmation required
- true
Source ID
H51-024134A0800A3426C46D4712 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-2BB380978D5EF74DA36171EB - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fentanyl (opens in a new tab)
Source ID
H51-0FF7230429950CEF3FB1BD3F
Dosing source fields
Id
fentanylSource ID
H51-7CD1A590EC83080BF46BC6F3Generic name
FentanylSource ID
H51-00F6EFB9C37CF02717979DE3Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-5D44755A0A918E8721EF144BPackage insert
- Query name
- Fentanyl
Source ID
H51-47E5796079B8FA50A8505A5D - Product and route must match
- true
Source ID
H51-573EE5739353A6766C728923 - Live current label enabled
- false
Source ID
H51-3640D508C4A85DFC33BDD41D - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-4B598DA8A79FF889ECB6CFA0 - Direct official label access enabled
- true
Source ID
H51-55F7B10DEBCA5E3BD380459E - Outbound server request required
- false
Source ID
H51-2B86A080B6FEAFBA8E6FD483 - Local summary status
- not_bundled
Source ID
H51-4CB4A3A5BBCB5DB4308C299A
Clinical review
- Locally normalized
- false
Source ID
H51-FD1D949B22157873522BD117 - Reviewed
- 2026-08-29
Source ID
H51-DD93AC053CD60E3E2A4A5D7D - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-EC0995914403DD9FEA27E61D
Clinical release verification
- Audit version
- 3.4
Source ID
H51-EC5294E77A0AD396D26A5FFA - Audited on
- 2026-08-30
Source ID
H51-28D956FC956BE514372C511F - Level
- amber
Source ID
H51-2D81E98E190278C64AF9E7D8 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-B5A44EF5B71D371D73A722B8 - Exact current label candidate
- false
Source ID
H51-765E9B67EFB016E1579C15CC - Numeric support ratio
- 0
Source ID
H51-3583F889056CBC34F4BF2B79 - Reference url count
- 1
Source ID
H51-A618083BA64C5EA24154587C - Broken reference count
- 0
Source ID
H51-43F1B6707BAABDFA0264C86D - Point of use confirmation required
- true
Source ID
H51-AB6B4ED3EA241AF2A69C1BE0 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-46FC5A68780288A5818C7ACB - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fentanyl (opens in a new tab)
Source ID
H51-5D3D4F35F1AEEA345A241DC0
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- fentanyl
Source ID
H51-5AACCC949396E16667FA7A02 - Name
- Fentanyl
Source ID
H51-21BC3DCDEA1A45792F7DF62A - Brands
- Sublimaze
Source ID
H51-F6694D69AD850997FBC20C79 - Therapeutic class
- Sedation, analgesia, and anesthesia
Source ID
H51-554D27909F021F501A34EC6B - Review version
- 3.1
Source ID
H51-9EC9A798EE441033B269A060 - Review date
- 2026-08-30
Source ID
H51-67DD9325E1C4F958ED2D35D7 - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-D7F24E86B981D865C5E96ED4 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-FEE35FC48907FA1BD35741C7 - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-DCAEADDE4950447A48BFB14B
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-EC4C7682051E76EE76ACD9CD - Reconstitution concentration
- Dilute concentrate or use premix.
Source ID
H51-762E204B49300F0883B08646 - Maximum or recommended final concentration
- 10 to 50 mcg/mL standardized concentration
Source ID
H51-4BEB50FC588C3D3925AA9B95 - Appropriate standardized containers
- 100 to 250 mL
Source ID
H51-55925282096F1F822E6EC2C5 - Adult dosing range
- Patient-specific dose; common bag 1,000 or 2,500 mcg Common incremental dose 25 to 100 mcg Weight-based dose 25 to 50 mcg/hour commonly Common incremental dose 25 to 100 mcg Weight-based dose
Source ID
H51-98013553A8748E126E182118 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-3C500394C50811D8C0FA715A - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-A56FA3DA60DC3AE8BB0B4957 - Infusion time
- Titrate by mcg/hour or mcg/kg/hour Slow IV over 1 to 2 minutes Slow IV over 1 to 3 minutes 25 to 50 mcg/hour commonly
Source ID
H51-4BF7F112CC2B36B71AD4460B - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-1E2EF5A198E95C72415B7BD4 - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-CEA9284C1F70A9B9D65E826C - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fentanyl (opens in a new tab)
Source ID
H51-277BE49B2B47F3BCCB108BEF
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-209B823A6806B3A6D322F7CE
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-D304F39CD298C32FA97ABE4B
- Maximum or recommended final concentration
- Primary
- existing_structured_record
Source ID
H51-505C2C64583F282B725B5421
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-AA1C1BD227483D8098D64C5B
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-49E2B78774EDF041B8DC91B0
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-6C3530521C69B47E151E7531
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-B6741FABB33A478D1FFC7CD3
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-D5E935C50C47E13AF3F2EA7A
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-A09C9B2BF8E883D1583039D1
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-E9192FADD28C758F0CA654DB
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-9EA11DD59C29051B2AFD9B27 - Guide generation allowed
- true
Source ID
H51-CD92BFD854DA6FB89ADFB333
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-6E475F68F4CB25A8E06A1ED2 - Guide generation allowed
- false
Source ID
H51-30AC23E8F69C3A156CC8EAFD
- Neonatal
- Applicability
- supported_or_source_present
Source ID
H51-F716BEEAAD768DAFB84A0121 - Guide generation allowed
- false
Source ID
H51-9920C5AC571108CBD518951C
- Route presence
- Structured dilution
- true
Source ID
H51-411CB0F060E4CCC2CAB762A2 - Iv push
- true
Source ID
H51-0F9C23754F088A5E692E152D - Continuous infusion
- true
Source ID
H51-8D294A74F79AB8045B05AB6A - Pediatric source
- true
Source ID
H51-36494AC209A0353095F667FB - Neonatal source
- true
Source ID
H51-7AC9DFD8D4F77484C93ABB14
- Legacy reference
- Status
- not_available
Source ID
H51-631F5B2B25438E4BF4F40C97
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-150D2D015270B65381A24968
- Concentration values detected
Low High Unit Text 10Source ID
H51-476DF6039AD65D36FC6793F2Source ID
H51-FD17164F0E33D6B943647AB850 Source ID
H51-427DDD207406CC9EC556ADD7mcg Source ID
H51-053DAF8DEB55D8B61A0A953710 to 50 mcg/mL Source ID
H51-7F0D203345A8880CC836AEF9- Source files
- catalog.json
Source ID
H51-9F9CD996F4DBF7ADB139EFDB - dosing.json
Source ID
H51-7F433287F946BC8BBB0BE76C - legacy-map.json
Source ID
H51-F493AC5F5A9288E9C4534B42
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-BD39F2F3F75B27B90871A5B0
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-94607B6BC2D935A50E4245AD | catalog.json/records/102/id | Historical; current review incomplete |
H51-2C2FC1D2FDBC3BE5FA14645F | catalog.json/records/102/generic_name | Historical; current review incomplete |
H51-586364D5B0CF4CF9C38E2577 | catalog.json/records/102/brand_names/0 | Historical; current review incomplete |
H51-C7B473FC50A8BA1FAD57B233 | catalog.json/records/102/class | Historical; current review incomplete |
H51-920F841AB0423AF90DB45568 | catalog.json/records/102/subclass | Historical; current review incomplete |
H51-4548E17485313E46148A6E8C | catalog.json/records/102/summary | Historical; current review incomplete |
H51-085CB1778D5DAB3B4F45C0E2 | catalog.json/records/102/common_uses/0 | Historical; current review incomplete |
H51-8A1E45B5A031A916B88D2B6A | catalog.json/records/102/common_uses/1 | Historical; current review incomplete |
H51-3EB280BA6EE60EC399151004 | catalog.json/records/102/common_uses/2 | Historical; current review incomplete |
H51-233D27322DDA921EA9959B65 | catalog.json/records/102/preparations/0 | Historical; current review incomplete |
H51-D70AB7A1EF1453789F5A1728 | catalog.json/records/102/preparations/0/population | Historical; current review incomplete |
H51-AD585CCF1B6E88BEF8E063E0 | catalog.json/records/102/preparations/0/amount | Historical; current review incomplete |
H51-5DDB8A51464E6B4422724492 | catalog.json/records/102/preparations/0/reconstitution | Historical; current review incomplete |
H51-5AE2329D48DE0049E031C323 | catalog.json/records/102/preparations/0/diluent | Historical; current review incomplete |
H51-9B4FE63CC88372B0104DD903 | catalog.json/records/102/preparations/0/final_volume | Historical; current review incomplete |
H51-D2D84BA1DBA4D760B80DDC52 | catalog.json/records/102/preparations/0/concentration | Historical; current review incomplete |
H51-B4E101806A0FE539E8EC8764 | catalog.json/records/102/preparations/0/rate | Historical; current review incomplete |
H51-7002235CB1C9C129F6A1B5B5 | catalog.json/records/102/preparations/0/stability | Historical; current review incomplete |
H51-84354955E54D574FDB0BB4F2 | catalog.json/records/102/preparations/0/notes | Historical; current review incomplete |
H51-A758FCB485AFB02A7F12FE96 | catalog.json/records/102/iv_push/0 | Historical; current review incomplete |
H51-D25E34B88C48BA1FFCBA21B7 | catalog.json/records/102/iv_push/0/population | Historical; current review incomplete |
H51-B15366C74C7F28686DCC5B5F | catalog.json/records/102/iv_push/0/dose_scope | Historical; current review incomplete |
H51-ACAA1C9CC362266391C0C7B9 | catalog.json/records/102/iv_push/0/concentration | Historical; current review incomplete |
H51-D72DCBDBE517121A7D534ABD | catalog.json/records/102/iv_push/0/rate | Historical; current review incomplete |
H51-7EF7E757737288DBE1182FC5 | catalog.json/records/102/iv_push/0/status | Historical; current review incomplete |
H51-401DD59FFB41591AB1173F42 | catalog.json/records/102/iv_push/0/notes | Historical; current review incomplete |
H51-B511E03D0640968917F5FEE0 | catalog.json/records/102/iv_push/1 | Historical; current review incomplete |
H51-927253A5E66498C4D8A86727 | catalog.json/records/102/iv_push/1/population | Historical; current review incomplete |
H51-E4EB1F737D26827561C32053 | catalog.json/records/102/iv_push/1/dose_scope | Historical; current review incomplete |
H51-F21471F106E73384C29E3384 | catalog.json/records/102/iv_push/1/concentration | Historical; current review incomplete |
H51-61E90E8DBF613A8B14E4A3E4 | catalog.json/records/102/iv_push/1/rate | Historical; current review incomplete |
H51-FB8C54B93C2DC970CCF6EF5F | catalog.json/records/102/iv_push/1/status | Historical; current review incomplete |
H51-88F4F48B3F20C6CD3D17DF6E | catalog.json/records/102/iv_push/1/notes | Historical; current review incomplete |
H51-66A0237AF792EACC79E6F296 | catalog.json/records/102/continuous_infusions/0 | Historical; current review incomplete |
H51-540F014C9223E28CD3CCF356 | catalog.json/records/102/continuous_infusions/0/population | Historical; current review incomplete |
H51-7D2CD836B50ED9B2DEA5B503 | catalog.json/records/102/continuous_infusions/0/standard_concentration | Historical; current review incomplete |
H51-366C31ED6EFC7FB30414FA10 | catalog.json/records/102/continuous_infusions/0/initial_rate | Historical; current review incomplete |
H51-42F844AB75B925DD1DAB3717 | catalog.json/records/102/continuous_infusions/0/titration | Historical; current review incomplete |
H51-BEFFB9356014B0148A4FDF0A | catalog.json/records/102/continuous_infusions/0/maximum | Historical; current review incomplete |
H51-968B5023C6370EC13CC22EF4 | catalog.json/records/102/continuous_infusions/0/notes | Historical; current review incomplete |
H51-DD3B93F3209ABF8E32DD967B | catalog.json/records/102/warnings/0 | Historical; current review incomplete |
H51-1AABA60771B823C3A6487055 | catalog.json/records/102/warnings/1 | Historical; current review incomplete |
H51-6461158547682E620F1561A2 | catalog.json/records/102/monitoring/0 | Historical; current review incomplete |
H51-273715E42BE6627FB48277D8 | catalog.json/records/102/monitoring/1 | Historical; current review incomplete |
H51-8A59133C75CE204F21464C15 | catalog.json/records/102/monitoring/2 | Historical; current review incomplete |
H51-EFB295CA84E31853AF53FFB2 | catalog.json/records/102/populations/0 | Historical; current review incomplete |
H51-2AEF461371DD94F2E875012A | catalog.json/records/102/populations/1 | Historical; current review incomplete |
H51-60F4CEE0A1BE997651A3FAE2 | catalog.json/records/102/populations/2 | Historical; current review incomplete |
H51-56D9673972927C08053848B9 | catalog.json/records/102/evidence_tier | Historical; current review incomplete |
H51-B7ECD1B8F92FE9FB57DC4363 | catalog.json/records/102/high_alert | Historical; current review incomplete |
H51-FA99D64D442728D2F11DB431 | catalog.json/records/102/hazardous | Historical; current review incomplete |
H51-05220F136CBA81F49ACAECA4 | catalog.json/records/102/status | Historical; current review incomplete |
H51-020B19918ED8CBADE72A84FD | catalog.json/records/102/reviewed | Historical; current review incomplete |
H51-8C47D19E71C0E7CCAC5ED3DD | catalog.json/records/102/version_added | Historical; current review incomplete |
H51-36FBC1846FA13F98A897433B | catalog.json/records/102/sources/0 | Historical; current review incomplete |
H51-F7BD2D5F8903C84647EC1B14 | catalog.json/records/102/sources/0/label | Historical; current review incomplete |
H51-B0932E7598BCAAE5FB46D436 | catalog.json/records/102/sources/0/url | Historical; current review incomplete |
H51-722959DC22BC38938F56EE14 | catalog.json/records/102/sources/0/kind | Historical; current review incomplete |
H51-C83047E1392E58A3B4F7F115 | catalog.json/records/102/sources/1 | Historical; current review incomplete |
H51-D3886AF1113EBD99B4F2DE18 | catalog.json/records/102/sources/1/label | Historical; current review incomplete |
H51-11E39F1A01880F0FFB3E34D4 | catalog.json/records/102/sources/1/url | Historical; current review incomplete |
H51-459DB341443BCD46F225DA25 | catalog.json/records/102/sources/1/kind | Historical; current review incomplete |
H51-612F3D45A066894E911C36B5 | catalog.json/records/102/legacy_title | Historical; current review incomplete |
H51-EB1356531669901C43811FE3 | catalog.json/records/102/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-5024EAD5CE9DC9440697F31D | catalog.json/records/102/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-63D472ED8BA69B13218684AA | catalog.json/records/102/clinical_release_verification/level | Historical; current review incomplete |
H51-40ECE910F07600000BDA3359 | catalog.json/records/102/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-48287B25B5640DA7AE1A280A | catalog.json/records/102/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-2DC22FC5D3F61F46D55B4EC4 | catalog.json/records/102/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-C24ACD63E0B69EF4DA9D906F | catalog.json/records/102/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-DC9129E1D1630334CC9F84F1 | catalog.json/records/102/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-4CF3B8E3D3EE4E17A6A29170 | catalog.json/records/102/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-BE2980F6B96961D34BCAD53B | catalog.json/records/102/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-024134A0800A3426C46D4712 | catalog.json/records/102/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-2BB380978D5EF74DA36171EB | catalog.json/records/102/clinical_release_verification/note | Historical; current review incomplete |
H51-0FF7230429950CEF3FB1BD3F | catalog.json/records/102/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-7CD1A590EC83080BF46BC6F3 | dosing.json/records/102/id | Historical; current review incomplete |
H51-00F6EFB9C37CF02717979DE3 | dosing.json/records/102/generic_name | Historical; current review incomplete |
H51-5D44755A0A918E8721EF144B | dosing.json/records/102/coverage_status | Historical; current review incomplete |
H51-47E5796079B8FA50A8505A5D | dosing.json/records/102/package_insert/query_name | Historical; current review incomplete |
H51-15F4CBC88ECD3AFD68FA4972 | dosing.json/records/102/package_insert/preferred_setid | Historical; current review incomplete |
H51-573EE5739353A6766C728923 | dosing.json/records/102/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-3640D508C4A85DFC33BDD41D | dosing.json/records/102/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-4B598DA8A79FF889ECB6CFA0 | dosing.json/records/102/package_insert/source_priority | Historical; current review incomplete |
H51-55F7B10DEBCA5E3BD380459E | dosing.json/records/102/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-2B86A080B6FEAFBA8E6FD483 | dosing.json/records/102/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-4CB4A3A5BBCB5DB4308C299A | dosing.json/records/102/package_insert/local_summary_status | Historical; current review incomplete |
H51-41E73D0EF4C6216C8DD0A53E | dosing.json/records/102/renal/classification | Historical; current review incomplete |
H51-E537777DC8261F395BAE6B39 | dosing.json/records/102/renal/summary | Historical; current review incomplete |
H51-AE14236F46024A5330698DC0 | dosing.json/records/102/renal/method_note | Historical; current review incomplete |
H51-B4740A7EAA9B0025CC1FD78A | dosing.json/records/102/existing_route_snapshots/0 | Historical; current review incomplete |
H51-E79A2100AC80E1F25C097CB9 | dosing.json/records/102/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-19B15B1C745D2DA795CB4084 | dosing.json/records/102/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-D66258A1692876C876ABDD88 | dosing.json/records/102/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-88F5846920CECF49B3085798 | dosing.json/records/102/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-8141CDA700702E56CE538A42 | dosing.json/records/102/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-9A328E57E386FED52A43DE98 | dosing.json/records/102/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-E01A8436E6FCE8D9F5225A53 | dosing.json/records/102/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-0E60F9442D36E4F126F5A3A4 | dosing.json/records/102/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-C8948BDC424A32E5022EEA04 | dosing.json/records/102/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-CAE63CE7245CA03A50CB4BE9 | dosing.json/records/102/existing_route_snapshots/1 | Historical; current review incomplete |
H51-0707188DE73EF3ACA5FA3847 | dosing.json/records/102/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-5C72C750B39F69FDE19BDEC3 | dosing.json/records/102/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-B77F1432641DA65F1D9DDA6C | dosing.json/records/102/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-5EBB1A2F0D338E6F2B00991E | dosing.json/records/102/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-E389BD895AAD7DB5B74706A8 | dosing.json/records/102/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-ED28F3F94963AF47B51EB723 | dosing.json/records/102/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-5AD3247A5E974A1009BA1963 | dosing.json/records/102/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-9570EB03EC74A8B3F6C88130 | dosing.json/records/102/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-DEB721B93B570052B1102390 | dosing.json/records/102/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-7B948372CBE0BA06CF5131A4 | dosing.json/records/102/existing_route_snapshots/2 | Historical; current review incomplete |
H51-4952FD40A25F63B11D8EAC8D | dosing.json/records/102/existing_route_snapshots/2/route | Historical; current review incomplete |
H51-C63A216AB3C2B6C54F35EC34 | dosing.json/records/102/existing_route_snapshots/2/population | Historical; current review incomplete |
H51-16F7D0821BDAA17DC258D068 | dosing.json/records/102/existing_route_snapshots/2/indication | Historical; current review incomplete |
H51-CA2294C7229AB7A93DA4032E | dosing.json/records/102/existing_route_snapshots/2/dose | Historical; current review incomplete |
H51-99D6BB8D507F1D5E0F1FBA8B | dosing.json/records/102/existing_route_snapshots/2/interval | Historical; current review incomplete |
H51-A19E96058EFEB902F6D0F647 | dosing.json/records/102/existing_route_snapshots/2/duration | Historical; current review incomplete |
H51-A33D1CE939320AE08B32DCCA | dosing.json/records/102/existing_route_snapshots/2/administration | Historical; current review incomplete |
H51-B14F2096635D5BA7E5B5F7D6 | dosing.json/records/102/existing_route_snapshots/2/source_level | Historical; current review incomplete |
H51-368AC37AF1083046B4051579 | dosing.json/records/102/existing_route_snapshots/2/notes | Historical; current review incomplete |
H51-07FA86B2D47A26B6B19177FA | dosing.json/records/102/existing_route_snapshots/3 | Historical; current review incomplete |
H51-9E184A47918C2FE94E8141D4 | dosing.json/records/102/existing_route_snapshots/3/route | Historical; current review incomplete |
H51-4D0544870A83BEA9943F0232 | dosing.json/records/102/existing_route_snapshots/3/population | Historical; current review incomplete |
H51-3A7D5ACC7F8D1D887EF65D67 | dosing.json/records/102/existing_route_snapshots/3/indication | Historical; current review incomplete |
H51-42A1902868A9633AAE6A3A0F | dosing.json/records/102/existing_route_snapshots/3/dose | Historical; current review incomplete |
H51-1692988151B7041175FB2033 | dosing.json/records/102/existing_route_snapshots/3/interval | Historical; current review incomplete |
H51-9424B098FF04618D8FADC488 | dosing.json/records/102/existing_route_snapshots/3/duration | Historical; current review incomplete |
H51-9B4D611AB7319502D79E860B | dosing.json/records/102/existing_route_snapshots/3/administration | Historical; current review incomplete |
H51-5F96767C09C7DFB69CDC24D3 | dosing.json/records/102/existing_route_snapshots/3/source_level | Historical; current review incomplete |
H51-F7C8354CF22E2976ACEDE72A | dosing.json/records/102/existing_route_snapshots/3/notes | Historical; current review incomplete |
H51-FD1D949B22157873522BD117 | dosing.json/records/102/clinical_review/locally_normalized | Historical; current review incomplete |
H51-DD93AC053CD60E3E2A4A5D7D | dosing.json/records/102/clinical_review/reviewed | Historical; current review incomplete |
H51-EC0995914403DD9FEA27E61D | dosing.json/records/102/clinical_review/status | Historical; current review incomplete |
H51-EC5294E77A0AD396D26A5FFA | dosing.json/records/102/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-28D956FC956BE514372C511F | dosing.json/records/102/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-2D81E98E190278C64AF9E7D8 | dosing.json/records/102/clinical_release_verification/level | Historical; current review incomplete |
H51-B5A44EF5B71D371D73A722B8 | dosing.json/records/102/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-765E9B67EFB016E1579C15CC | dosing.json/records/102/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-290A74C58E1EC8BC47AE83BE | dosing.json/records/102/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-83A289703E2635C94CAA108D | dosing.json/records/102/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-3583F889056CBC34F4BF2B79 | dosing.json/records/102/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-A618083BA64C5EA24154587C | dosing.json/records/102/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-43F1B6707BAABDFA0264C86D | dosing.json/records/102/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-AB6B4ED3EA241AF2A69C1BE0 | dosing.json/records/102/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-46FC5A68780288A5818C7ACB | dosing.json/records/102/clinical_release_verification/note | Historical; current review incomplete |
H51-5D3D4F35F1AEEA345A241DC0 | dosing.json/records/102/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-08BE96338526854050BF8B28 | first-look-v5.1.json/records/102/id | Historical; current review incomplete |
H51-F0D97DD6C1BA088AAF200374 | first-look-v5.1.json/records/102/generic_name | Historical; current review incomplete |
H51-EF8EAF853F9DBA93E8955EA3 | first-look-v5.1.json/records/102/class | Historical; current review incomplete |
H51-3704C0A9C88CAFEFF4EBD05A | first-look-v5.1.json/records/102/subclass | Historical; current review incomplete |
H51-32F3E74C18374975E003C7C7 | first-look-v5.1.json/records/102/primary_uses/0 | Historical; current review incomplete |
H51-3713D5147108F1637C6741BC | first-look-v5.1.json/records/102/primary_uses/1 | Historical; current review incomplete |
H51-D35A001A04C277A76CDC21E0 | first-look-v5.1.json/records/102/primary_uses/2 | Historical; current review incomplete |
H51-01748F14C6EEB16B2AB6CDA7 | first-look-v5.1.json/records/102/mechanism | Historical; current review incomplete |
H51-4C35E0C67215D146E03F2055 | first-look-v5.1.json/records/102/mechanism_level | Historical; current review incomplete |
H51-D225413523FFEE8A32D8568A | first-look-v5.1.json/records/102/basic_dosing_orientation | Historical; current review incomplete |
H51-09505A77E6C475E842B212B8 | first-look-v5.1.json/records/102/administration_orientation | Historical; current review incomplete |
H51-1C4D9EB593547BBC6C66D34E | first-look-v5.1.json/records/102/renal_and_population_orientation | Historical; current review incomplete |
H51-C005AA050CEBFD3B09140644 | first-look-v5.1.json/records/102/key_safety_orientation/0 | Historical; current review incomplete |
H51-651E8490D8C82DF6FA5843EC | first-look-v5.1.json/records/102/key_safety_orientation/1 | Historical; current review incomplete |
H51-3D12E8C6DA0DDA231A53078A | first-look-v5.1.json/records/102/coverage_path | Historical; current review incomplete |
H51-E1DE7F2458716A3FCF031B4E | first-look-v5.1.json/records/102/coverage_path_label | Historical; current review incomplete |
H51-8973109D25A8A6EA79CC0150 | first-look-v5.1.json/records/102/official_label_url | Historical; current review incomplete |
H51-E755B655070DA6F9E7DA362B | first-look-v5.1.json/records/102/legacy_title | Historical; current review incomplete |
H51-56E4BD09F57405A73542BBD0 | first-look-v5.1.json/records/102/review_note | Historical; current review incomplete |
H51-D4A9E8DC82C221F93F7ED886 | first-look-v5.1.json/records/102/search_text | Historical; current review incomplete |
H51-5C058A7C9076A7F68557927F | first-look-v5.1.json/records/102/official_search_url | Historical; current review incomplete |
H51-5908DB30FD14906FC40B4E3C | first-look-v5.1.json/records/102/official_access_mode | Historical; current review incomplete |
H51-B312BCB7B04922937D35F373 | first-look-v5.1.json/records/102/official_access_url | Historical; current review incomplete |
H51-E6C049FF9C2FEA92A686DBF0 | first-look-v5.1.json/records/102/official_search_query | Historical; current review incomplete |
H51-97F369DF652C52ACF4C266EC | first-look-v5.1.json/records/102/official_access_reason | Historical; current review incomplete |
H51-5AACCC949396E16667FA7A02 | preparation-assessments-v3.8.json/102/id | Historical; current review incomplete |
H51-21BC3DCDEA1A45792F7DF62A | preparation-assessments-v3.8.json/102/name | Historical; current review incomplete |
H51-F6694D69AD850997FBC20C79 | preparation-assessments-v3.8.json/102/brands | Historical; current review incomplete |
H51-554D27909F021F501A34EC6B | preparation-assessments-v3.8.json/102/therapeutic_class | Historical; current review incomplete |
H51-9EC9A798EE441033B269A060 | preparation-assessments-v3.8.json/102/review_version | Historical; current review incomplete |
H51-67DD9325E1C4F958ED2D35D7 | preparation-assessments-v3.8.json/102/review_date | Historical; current review incomplete |
H51-D7F24E86B981D865C5E96ED4 | preparation-assessments-v3.8.json/102/release_status | Historical; current review incomplete |
H51-FEE35FC48907FA1BD35741C7 | preparation-assessments-v3.8.json/102/market_status/status | Historical; current review incomplete |
H51-DCAEADDE4950447A48BFB14B | preparation-assessments-v3.8.json/102/market_status/basis | Historical; current review incomplete |
H51-EC4C7682051E76EE76ACD9CD | preparation-assessments-v3.8.json/102/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-762E204B49300F0883B08646 | preparation-assessments-v3.8.json/102/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-4BEB50FC588C3D3925AA9B95 | preparation-assessments-v3.8.json/102/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-55925282096F1F822E6EC2C5 | preparation-assessments-v3.8.json/102/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-98013553A8748E126E182118 | preparation-assessments-v3.8.json/102/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-3C500394C50811D8C0FA715A | preparation-assessments-v3.8.json/102/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-A56FA3DA60DC3AE8BB0B4957 | preparation-assessments-v3.8.json/102/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-4BF7F112CC2B36B71AD4460B | preparation-assessments-v3.8.json/102/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-1E2EF5A198E95C72415B7BD4 | preparation-assessments-v3.8.json/102/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-4D1C6623EA6F603DE9DA2469 | preparation-assessments-v3.8.json/102/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-10AA26CCB6594F9CD3E2A899 | preparation-assessments-v3.8.json/102/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-65B19B4BF6B7CFBBCBA4D63F | preparation-assessments-v3.8.json/102/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-2BF4877E8CD43165901F27B5 | preparation-assessments-v3.8.json/102/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-CEA9284C1F70A9B9D65E826C | preparation-assessments-v3.8.json/102/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-277BE49B2B47F3BCCB108BEF | preparation-assessments-v3.8.json/102/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-209B823A6806B3A6D322F7CE | preparation-assessments-v3.8.json/102/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-D304F39CD298C32FA97ABE4B | preparation-assessments-v3.8.json/102/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-505C2C64583F282B725B5421 | preparation-assessments-v3.8.json/102/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-AA1C1BD227483D8098D64C5B | preparation-assessments-v3.8.json/102/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-49E2B78774EDF041B8DC91B0 | preparation-assessments-v3.8.json/102/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-6C3530521C69B47E151E7531 | preparation-assessments-v3.8.json/102/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-B6741FABB33A478D1FFC7CD3 | preparation-assessments-v3.8.json/102/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-D5E935C50C47E13AF3F2EA7A | preparation-assessments-v3.8.json/102/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-A09C9B2BF8E883D1583039D1 | preparation-assessments-v3.8.json/102/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-E9192FADD28C758F0CA654DB | preparation-assessments-v3.8.json/102/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-9EA11DD59C29051B2AFD9B27 | preparation-assessments-v3.8.json/102/population_applicability/adult/applicability | Historical; current review incomplete |
H51-CD92BFD854DA6FB89ADFB333 | preparation-assessments-v3.8.json/102/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-6E475F68F4CB25A8E06A1ED2 | preparation-assessments-v3.8.json/102/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-30AC23E8F69C3A156CC8EAFD | preparation-assessments-v3.8.json/102/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-F716BEEAAD768DAFB84A0121 | preparation-assessments-v3.8.json/102/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-9920C5AC571108CBD518951C | preparation-assessments-v3.8.json/102/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-411CB0F060E4CCC2CAB762A2 | preparation-assessments-v3.8.json/102/route_presence/structured_dilution | Historical; current review incomplete |
H51-0F9C23754F088A5E692E152D | preparation-assessments-v3.8.json/102/route_presence/iv_push | Historical; current review incomplete |
H51-8D294A74F79AB8045B05AB6A | preparation-assessments-v3.8.json/102/route_presence/continuous_infusion | Historical; current review incomplete |
H51-36494AC209A0353095F667FB | preparation-assessments-v3.8.json/102/route_presence/pediatric_source | Historical; current review incomplete |
H51-7AC9DFD8D4F77484C93ABB14 | preparation-assessments-v3.8.json/102/route_presence/neonatal_source | Historical; current review incomplete |
H51-631F5B2B25438E4BF4F40C97 | preparation-assessments-v3.8.json/102/legacy_reference/status | Historical; current review incomplete |
H51-150D2D015270B65381A24968 | preparation-assessments-v3.8.json/102/label_resolution/status | Historical; current review incomplete |
H51-476DF6039AD65D36FC6793F2 | preparation-assessments-v3.8.json/102/concentration_values_detected/0 | Historical; current review incomplete |
H51-FD17164F0E33D6B943647AB8 | preparation-assessments-v3.8.json/102/concentration_values_detected/0/low | Historical; current review incomplete |
H51-427DDD207406CC9EC556ADD7 | preparation-assessments-v3.8.json/102/concentration_values_detected/0/high | Historical; current review incomplete |
H51-053DAF8DEB55D8B61A0A9537 | preparation-assessments-v3.8.json/102/concentration_values_detected/0/unit | Historical; current review incomplete |
H51-7F0D203345A8880CC836AEF9 | preparation-assessments-v3.8.json/102/concentration_values_detected/0/text | Historical; current review incomplete |
H51-9F9CD996F4DBF7ADB139EFDB | preparation-assessments-v3.8.json/102/source_files/0 | Historical; current review incomplete |
H51-7F433287F946BC8BBB0BE76C | preparation-assessments-v3.8.json/102/source_files/1 | Historical; current review incomplete |
H51-F493AC5F5A9288E9C4534B42 | preparation-assessments-v3.8.json/102/source_files/2 | Historical; current review incomplete |
H51-BD39F2F3F75B27B90871A5B0 | preparation-assessments-v3.8.json/102/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)
